PRIVIGEN in English translation

• privigen

Examples of using Privigen in Croatian and their translations into English

Kako primjenjivati Privigen.
How to use Privigen.

Kako čuvati Privigen.
How to store Privigen.

Kako Privigen djeluje.
How Privigen works.

Privigen sadrži prolin.
Privigen contains proline.

Zašto je Privigen odobren?
Why has Privigen been approved?

Drugi lijekovi i Privigen.
Other medicines and Privigen.

Kako je Privigen ispitivan?
How has Privigen been studied?

Privigen sadrži zanemarive količine natrija.
Privigen is essentially sodium free.

Privigen je otopina za infuziju.
Privigen is presented as a solution for infusion.

Kako Privigen izgleda i sadržaj pakiranja.
What Privigen looks like and contents of the pack.

Privigen u osnovi ne sadrži natrij.
Privigen is essentially sodium-free.

U početku infuzije primat ćete Privigen malom brzinom.
At the beginning of the infusion you will receive Privigen at a slow infusion rate.

druge informacije Što Privigen sadrži.
other information What Privigen contains.

Privigen 100 mg/ml(10%) otopina za infuziju.
Privigen 100 mg/ml(10%) solution for infusion.

Privigen sadrži imunoglobuline koji su izolirani iz plazme krvi zdravih ljudi.
Privigen contains immunoglobulins that have been prepared from the blood of healthy people.

Privigen se isporučuje kao otopina spremna za uporabu u bočicama za jednokratnu uporabu.
Privigen comes as a ready-to-use solution in single-use vials.

S obzirom da otopina ne sadrži konzervanse, Privigen treba odmah primijeniti infuzijom.
Because the solution contains no preservative, Privigen should be infused immediately.

Vaš liječnik će odlučiti možete li uzimati Privigen u vrijeme trudnoće ili dok dojite.
Your doctor will decide whether you can receive Privigen during your pregnancy or while you are breast-feeding.

Liječnik ili medicinska sestra uglavnom primjenjuju lijek Privigen kao infuziju u venu.
Privigen is usually given as an infusion into a vein by a doctor or nurse.

Farmakokinetički parametri za Privigen utvrđeni su u kliničkom ispitivanju u PID bolesnika vidjeti dio 5.1.
The pharmacokinetic parameters for Privigen were determined in a clinical study in PID patients see section 5.1.